Translocations in which the breakpoint is located near a JH segment are thought to be mediated by the VDJ recombination mechanism that occurs in the earliest stages of B-cell development. Alternatively, translocations in which the breakpoint is located near or within IgH switch regions are thought to be mediated by the IgH switch recombination mechanism that generally is active in late stages of B-cell development. Karyotypically detectable translocations involving chromosome band 14q32 occur in 10% to 40% of multiple myeloma (MM)
by errors in two different gene rearrangement mechanisms. Translocations in which the breakpoint is located near a JH segment are thought to be mediated by the VDJ recombination mechanism that occurs in the earliest stages of B-cell development. Alternatively, translocations in which the breakpoint is located near or within IgH switch regions are thought to be mediated by the IgH switch recombination mechanism that generally is active in late stages of B-cell development. Karyotypically detectable translocations involving chromosome band 14q32 occur in 10% to 40% of multiple myeloma (MM)
The other chromosome partner in this translocation can be identified in about 30% of these cases, when it is most frequently found to involve the chromosome 1 lq13 locus. Most mantle-cell lymphomas and some other kinds of B lymphomas have t(11;14) ( 4 3 ; q32) translocations; and in all cases analyzed, the breakpoint occurs near a JH region on chromosome 14 and near the BCLl locus on chromosome 11, resulting in dysregulation of the cyclin D1 gene.'.'' In contrast to mantle-cell lymphoma tumors, human MMs, like mouse plasmacytoma tumors, have undergone IgH switch recombination. Therefore, we decided to determine if the t(11;14)(q13;q32) breakpoints in MM can occur near or into IgH switch regions.
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MATERIALS AND METHODS
The human myeloma cell lines were grown in Petri dishes in RPMI-1640 supplemented with 10% fetal calf serum.*('.'' Chromosomal analysis was performed on cell lines MM-M1 and SK-MM2 by a G-banding method (Molecular Medicine, Rockville, MD).
The cell pellet was resuspended into lysis buffer (SO mmoUL Tris-HC1 pH 7.5,250 mmoUL NaCI, 5 mmolL EDTA, SO mmol/L NaF, 0.1 % NP40,O. 174 mg phenyl methylsulfonyl fluoride [PMSF]); after centrifugation, the supernatant was frozen in dry ice. Protein lysates (100 kg) were fractionated on an sodium dodecyl sulfate (SDS) 10% acrylamide gel and transferred for 4 hours at SO V to a nitrocellulose membrane (Schleicher & Schuell, Keene, NH).
The filter was blocked with 5% milk-1 % bovine serum albumin in phosphate-buffered saline (PBS), reacted for 4 hours at 4°C with a 11200 anti-cyclin D1 polyclonal rabbit antiserum (no. 92-92; Santa CNZ Biotechnology, Santa Cruz, CA) in blocking solution, washed three times with PBS, and then reacted with a 1/1,000 antirabbit IgG, horseradish peroxidase-linked antibody (NA 934; Amersham, Arlington Heights, IL) in PBS-0.1% Tween for 45 minutes. Reactive bands were detected using an ECL system (Amersham)." Total RNA was isolated from the cell lines by the addition to the pellet of 4 molL guanidine isothiocyanate and centrifugation through cesium chloride gradient. Fifteen micrograms of RNA was fractionated on a 1% agarose gel containing 0.22 molL formaldehyde, and then transferred with 20X SSC (3 molL sodium chloridd3 molL sodium citrate) to a membrane (Genescreenplus; DuPont-NEN Research Products, Boston, MA). After transfer, the filter was baked at 80°C for 2 hours."
High-molecular weight genomic DNA was coextracted and gradient-purified with RNA, or was prepared directly. Ten micrograms was digested with the appropriate restriction enzyme, fractionated by gel electrophoresis on a 0.6% agarose gel, denatured with 0.5N NaOH, 1.5 molL NaCI, neutralized with 1 molL Tris-HC1 pH7.4, 1.5 molL NaC1, and transferred overnight with 20x SSC onto membranes (GenescreenPlus)."
The p-actin probe was a 2.0-kb BamHl rabbit cDNA fragment. All other probes were amplified by polymerase chain reaction (PCR) using the following oligonucleotide (Genosys Biotechnologies, The Woodlands, TX) pairs, and annealing temperatures: Hybridization conditions. The filters were hybridized at 42°C overnight in I molL NaCI, 50 mmol/L Tris-HC1 pH 7.4, 40% formamide. 10% dextran sulfate, 1% SDS, 1 0 0 pg/mL sheared herring sperm DNA, plus 1 to 2 x IO6 cpmlmL of probe, then washed in 2X SSC, 0.1 % SDS at 22T, and in 0.1 X SSC, 0. I % SDS at 55 to 60°C. and exposed to XAR-5 film (Kodak, Rochester, NY) at -70°C with intensifying screen, or scanned on a Phosphorimager (Molecular Dynamics, Sunnyvale, CA).
Genomic libraries. KMSl2 DNA was digested with HindlIl and ligated into A DASH 11 replacement vector (Stratagene). SK-MM2 DNA was digested with HindIIl, ligated to EcoRl adaptors, and cloned into A ZAP I1 vector (Stratagene). After packaging the recombinant phage with the Gigapack I1 Gold kit (Stratagene), 500.000
GACClTGCAGTGACAAAACCAAG and 5 " C C C C A r n A Gpfu from the KMSl2 library, and 540,000 pfu from the SK-MM2 library were plated, and screened by hybridi7ation with the 3'-Sy probe. For the secondary screen, duplicated filters were hybridized separately with 3'-Sy and 5'-Sy probes to identify clones that hybridize only with the former probe. Five such clones were isolated from the KMS12 library, and a 4.5-kb Hindlll fragment was cloned into the pGEM 7Zf (Promega, Madison, WI) plasmid. For SK-"2, a pBlueScriptSK phagemide containing a 6.4-kb Hind111 fragment was in vivo excised from one of the four positive A ZAP IT phage.
An Rsal-Pstl fragment containing the breakpoint from SK-MM2 was further subcloned into pGEM5Zf (Promega). PI libraries were prepared and screened by Genome Systems (St Louis, MO).
DNA sequencing. All of the sequencing was performed by chain termination using Sequenase (US Biochemicals, Cleveland, OH) or by thermal cycle sequencing using thefmol DNA cycle sequencing kit (Promega). The 5'-and 3'-ends of the 4.5-kb HindlIl fragment from KMS12 and of the 6.4-kb Hind111 SK-MM2 fragment were sequenced using commercial oligonucleotides specific for the polylinkers of pGEM7Zf (T7 and SP6) and of pBluescript (T7 and T3: see Fig IC and D) . The KMS12 breakpoint sequence was obtained using the switch oligonucleotide #l (5'-AGGCTGCACTGCACTlTCAC) and the chromosome 1 I breakpoint oligonucleotide #2 (5'-CCTCCACCACTAATGTCACCA). For the SK-MM2 breakpoint sequence, we used a T7 commercial oligonucleotide (#3, Fig ID) For Somatic-cell hybrid analvsis. A PCR analysis, using the breakpoint clone oligonucleotide pairs (see earlier), was performed on a panel of hamster-human cell hybrids, each of which contains a single human chromosome (Coriell Cell Repository, Camden, NJ).
A panel of radiation-reduced somatic cell hybrids"." was used to characterize the KMS 12 and SK-MM2 breakpoints. Southem hybridization was performed on an EcoRl digest of the somatic-cell hybrid DNA, using KMS12 and SK-MM2 breakpoint probes K and S. respectively ( Fig  IC and D) . In addition, PCR analysis was performed on 100 ng of DNA from each of the hybrid lines, with the KMS12 and SK-MM2 breakpoint-specific primers.
YAC clones from a cloned contig in I lq13 (Smith and Gerhard, unpublished data) were assayed using a sequencetagged sites (STS) PCR-based approach'" for the presence of the KMSl2 and SK-MM2 sequences. DNA was prepared from each YAC according to the protocol described by Brownstein et ai." Locus-specific primers were used to PCR-amplify DNA from each YAC. The product from each cell line was separated by gel electrophoresis and photographed. The PCR results were confirmed by Southem hybridization of Hind111 and BamHl restriction-digested YACs with the KMS12-and SK-MM2-specific PCR probes.
Information regarding size of YACs and STS content was used in the computer program SEGMAP" to estimate the minimum distance between loci.
Radiation-reduced somatic-cell hvbrid analvsis.
YAC clones.
YAC conrig analwis.

RESULTS
Cyclin DI is highly expressed in 3/13 M M cell lines. We DI expression (Fig 2) . Analysis of Northern blots with a cyclin DI probe showed that three lines (MM-MI, KMS12, and SK-MM2) express similarly high levels of a 1.5-kb cyclin DI mRNA specie^*^.'^ (Fig 2A) and much lower levels of a 4.5-kb cyclin DI mRNA species. Several myeloma cell lines (8226, JJN3, and KMSI 1) express very low levels of the 4.5-kb cyclin DI mRNA species, but no detectable I .5-kb cyclin D I mRNA, raising the possibility that the translocation event may selectively enhance expression of the 1.5-kb mRNA species more than the 4.5-kb mRNA species. However, previous results with B-lymphoblastoid cell lines, mantle-cell lymphomas, and other B-cell tumors show predominant expression of the 4.5-kb mRNA species in some instances, but predominant expression of the 1.5-kb mRNA species in There does not appear to be a clear pattern of expression that correlates with the type of B cell o r B-cell tumor that was studied. By Western blot analysis, all three lines express similar amounts of an approximately 36-Kd cyclin DI protein (Fig 2B) ."-'6 t(l I : 14) is present in all three MM lines that overexpress cyclin DI. Karyotypes have been reported in the literature for two of the three lines that express high levels of cyclin DI. One line (KMS12) was reported to have an t( 1 I; 14)(q13;q32) translocation.*' Although the other line (SK-MM2) was reported as 14q32"" (ie, evidence of a translocation involving 14q32 and an unknown chromosomal partner), recent unpublished studies identify an t( I 1 ; 14)(ql3;q32) translocation (R.K.S. Chaganti, personal communication, March 1996). Finally, by karyotypic analysis, we determined that MM-MI has a t(l1;14)(q13;q32) translocation (data not shown).
For
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Southem blot assay to detect illegitimate switch recombinations. We developed a Southern blot assay to identify candidate translocations into switch regions to explore the hypothesis that IgH translocations in MM might occur from errors in IgH switch re~ombination.~' We generated pairs of short probes (one pair each for mu, gamma, epsilon, and alpha switch regions) that detect sequences immediately upstream and downstream of switch regions (eg, as shown for mu and gamma switch regions in Fig 1A) . Genomic DNA is digested with a restriction enzyme that recognizes sites flanking the pair of probes for each switch region and the resultant Southem blot hybridized sequentially with the appropriate probes. For each germline switch region, the upstream (5') and downstream (3') probes detect the same restriction fragment@). Legitimate switch recombination between any two switch regions results in generation of a restriction fragment that is detected by probes from two different switch regions. For example, physiological switch recombination (eg, mu to gamma as shown in Fig 1B) results in a hybrid mdgamma switch region that generates a restriction fragment that co-hybridizes with 5' Sp and 3' Sy probes. In contrast, illegitimate switch recombination, which involves only one switch region, generates one or two restriction fragments, each of which is uniquely detected by only one switch probe. Detection of an illegitimate switch recombination fragment identifies a candidate translocation breakpoint into an IgH switch region.
KMS12 and SK-MM2 have illegitimate Sy recombinations. We analyzed placental genomic DNA, as well as DNA from KMS12 ( Fig 3A) and SK-MM2 (Fig 3B) , by Southern blotting. As shown for KMS12 (Fig 3A) , we identified the following HindIII fragments: 5.4 and 1.7 kb with 5' Sp probe (lane 1); 4.3 and 3.7 kb with 5' Sy probe (lane 2); 4.7, 4.3, and 3.7 kb with 3' Sy probe (lane 3). The presence of a 4.7-kb fragment that was detected with a 3' Sy probe, but not with other switch probes (results with 5' Sp, a, and E probes not shown), indicates that this gamma switch region is involved in an illegitimate switch recombination event. For SK-MM2 (Fig 3B) , we identified the following HindIII fragments: 10. and E probes not shown) again suggests an illegitimate switch recombination event. Thus, for these two lines, there is molecular evidence consistent with a translocation involving a gamma switch region. Similar experiments were performed with genomic DNA from the MM-M1 cell line, but an illegitimate switch recombination fragment was not detected (data not shown).
In both lines the illegitimate Sy is a t(11;14)(q13;q32) breakpoint. Genomic libraries were made using HindIII digested DNA from the KMS12 and SK-MM2 lines. For KMS12, we obtained a clone (Fig IC) that hybridizes uniquely with the 3' S y probe, and contains a 4.7-kb HindIII fragment that was subcloned. Similarly, for SK-MM2, we rescued a plasmid containing a 6.4-kb HindIII insert that contains 3' Sy sequences (Fig 1D) . Sequence was obtained from each end of these two Hind111 fragments. As expected, for each fragment, the 3' end showed near identity to a 3' Sy sequence, but the sequences of the 5' ends could not be identified in the GENBANK data base in either case.
We prepared oligonucleotide pairs from the unknown sequences (Methods and Fig 1C and D) , and for each breakpoint clone developed a PCR assay that amplifies a fragment of predicted size from human placenta genomic DNA. The respective KMS12 and SK-MM2 PCR products (K, S in Fig 1C and D) hybridized to unique germline HindIII fragments in placental DNA (6.8 kb in Fig 3A, lane 5 , and 13 kb in Fig 3B, lane 6) . As expected, the respective PCR product hybridized to an additional translocation breakpoint HindIII fragment that cohybridized with a 3' Sy probe (4.7-kb fragment in Fig 3A, lane 4 for KMS12, and 6.4-kb fragment Fig 3B, lane 5 for SK-MM2) . By using the PCR assay to screen a panel of hamster-human somatic-cell hybrids, we then determined that each unknown sequence maps to chromosome 11 (data not shown).
The translocation breakpoint junctions were sequenced ( Fig 1C and D and Methods). These sequences were compared with the four human gamma switch regions using a Pustell plot matrix. The KMS 12 translocation breakpoint (Fig 4A and C) is in the 2330 to 2335 position of the gamma 2 switch sequence, while the SK-MM2 translocation breakpoint involves a gamma 1 switch region (Fig 4B and  D) . Although we cannot distinguish which of five 80-bp repetitive switch sequences is involved, we arbitrarily show a sequence comparison with the germline sequence marked by an asterisk. We do not know if sequence differences between the germline switch sequences and the switch sequences associated with the breakpoint are due to germline polymorphisms or mutations associated with the translocation process.
Having established that both the KMS12 and SK-MM2 MM lines have 11; 14 translocations into gamma switch regions, we sought to determine the site of the breakpoints on chromosome 11. We used two complementary methods to localize the sites of these two breakpoints. First, by the use of 1 lql3-specific radiation-reduced it was determined that both breakpoints map into the FGF3 segregation group, which is estimated to comprise approximately 3 mb, and include the CCNDl locus. Second, we screened a contig of 12 YACs that cover a region extending approximately 200 kb telomeric and 500 kb centromeric to the cyclin D1 gene (CCND1).26*38.39 The SK-MM2 sequence is contained within yWPRl1, a 300-kb YAC containing both pHS-11 BCLl and cyclin D1 sequences. In addition, a screen of a PI human genomic library (average insert, 1.100 kb) with the SK-MM2 PCR assay identified six independent clones, each of which also contained pHS-11 BCLl sequences. The three P1 clones analyzed further all lacked cyclin D1 sequences. We conclude that the SK-MM2 breakpoint must map near the MTC region, which is located approximately 63 kb centromeric to pHS-11 and approximately 110 kb centromeric to cyclin D1. In contrast, the KMS12 chromosome 11 part of the breakpoint sequence is not present in the panel of YACs, in a chromosome 11 YAC library, in two P1 human genomic DNA libraries, or in a human chro- Fig 1D. lanes 5 and 6) probes.
mosome I 1 cosmid library (unpublished data). However, as noted earlier from the radiation-reduced hybrid experiments, the KMS12 breakpoint is located on band l l q 1 3 within a few mb of cyclin DI.
DISCUSSION
Translocations involving the IgH locus at chromosomal locus 14q32.3 in B-lymphocyte malignancies are mediated by errors in two developmentally regulated, Iymphocytespecific gene rearrangement pathways: VDJ recombination that occurs early in development or IgH switch recombination that usually occurs late in development. For a given type of tumor, there is often a predominant partner chromosomal locus and corresponding oncogene that is dysregulated,' eg, BCL2 in follicular lymphoma:".4' BCLl (cyclin D1) in mantle-cell lymph~ma,"-'~.~'.~' and c-myc in Burkitt's lymphoma or mouse plasmacytoma Generally, for a given type of translocation, one of the two gene rearrangement pathways is predominant (eg, VDJ for BCL2 in follicular lymphoma and BCLl in mantle-cell lymphoma), although this predominance of one mechanism may be related to the type of B-cell tumor and not the partner chromosome or oncogene (eg. switch-mediated c-myc translocation in mouse plasmacytomas but VDJ-mediated c-myc translocations in endemic Burkitt's lymphomas determine if translocations into the llq13 locus would involve switch regions in MM.
We developed a Southern blot assay to detect illegitimate switch recombination fragments as candidates for translocation breakpoints. Three of 13 myeloma cell lines overexpress cyclin D1. In two of the three lines that overexpress cyclin D1, we isolated molecular clones derived from translocation of llq13 sequences into a gamma switch region (Sy2 in Kh4S12 and S y l in SK-MM2). For SK-MM2, we were able to map the translocation breakpoint to a region approximately 100 kb centromeric to cyclin D1 (CCNDl), a site near the MTC region that is often involved in the 11;14 translocations in mantle-cell lymphoma. For KMS 12, we were unable to determine more precisely the location of the chromosome 1 lq13 breakpoint sequence, suggesting the possibility that these sequences are difficult to clone or unstable in cosmid, P1, and YAC libraries (we have evidence that sequences in the BCLl locus are unstable in YAC clones, C.M.S. and D.S.G., unpublished data).
In the thitd myeloma cell line (MM-MI) that overexpresses cyclin DI, and also has a karyotypic t(11;14)(q13;q32), we were unable to detect an illegitimate switch recombination fragment. This could be due to the inability of our Southern blot assay to detect a switch recombination fragment, perhaps because the recombination event occurred outside of the probes andor restriction enzymes that were used. Alternatively, for this myeloma tumor, the 11; 14 translocation may have been mediated by an error in VDJ recombination. Using the MTC probe that detects the majority of VDJmediated translocation events in mantle-cell lymphoma,'* no rearrangement of the BCLl locus was detected in any of the three MM genomic DNAs, each of which was analyzed separately using five different restriction enzymes (M. Williams and M. Kuehl, unpublished data). Thus, we do not know the site and presumed mechanism of the t(l1; 14) (q13;q32) translocation in the MM.M1 MM cell line.
We suggest that in MM, cyclin D1 overexpression often is associated with t( 11; 14)(q13;q32) translocations that involve IgH switch regions, indicating that the translocation results from an error in IgH switch recombination. This result supports the idea presented earlier that the lymphocyte-specific gene rearrangement mechanism (VDJ v switch recombination) responsible for the error that leads to a translocation is associated mainly with the type of tumor, rather than with the chromosomal locus (oncogene) that is involved.
